-
National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)
Study
phs004180
-
HELIUS DAC
The HELIUS data are owned by the Amsterdam University Medical Centers, location AMC in Amsterdam, The Netherlands. To allow sharing of microbiome data collected in HELIUS with (inter)national researchers, 16s rRNA sequence analysis has been stored at the European genome-phenome archive (EGA; accession code EGAD00001004106). This requires that access needs to be granted, also because the HELIUS data are stored with relevant phenotypical variables. Access is granted to all researchers affiliated with an internationally recognized research institution who request to use the HELIUS data within the EGA context, after having signed the data transfer agreement. Any researcher can request the data by submitting a proposal to the HELIUS Executive Board as outlined at http://www.heliusstudy.nl/en/researchers/collaboration, by email: heliuscoordinator at amsterdamumc dot nl. The HELIUS Executive Board will check proposals if they do not conflict with ethical approvals and informed consent forms of the HELIUS study.
Dac
EGAC00001000895
-
Myocardial Applied Genomics Network (MAGNet) Study
Study
phs001539
-
24 Chordoma samples (WES,WGS)
Dataset
EGAD00001004825
-
Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma
Study
EGAS00001007426
-
CPTAC: Proteogenomic Studies of Ovarian Tumor Responses to Agents Targeting the DNA Damage Response
Study
phs003152
-
WES samples of patients with anti-PD-1 resistant HNSCC from a non-randomized, open-label phase 1b clinical trial
Study
EGAS50000000729
-
Center for Craniofacial and Dental Genetics (CCDG): Genetics of Orofacial Clefts, Sub-types, and Subclinical Phenotypes - CIDR
Study
phs002815
-
Variables of diversity, clonality, V and J usage and main COVID-19-reactive GLIPH2 frequencies.
Study
EGAS50000000587
-
Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases
Study
JGAS000627
-
Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases
Study
JGAS000296
-
Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases
Study
JGAS000486
-
VESPA: Vanderbilt Electronic Systems for Pharmacogenomic Assessment
Study
phs000991
-
DAC for "Longitudinal copy number variation analysis from plasma DNA of head and neck cancer patients under re-radiotherapy"
Dac
EGAC50000000114
-
HELIUS cohort
Study
EGAS00001002969
-
Federated discovery and sharing of genomic data using Beacons
Blog
federated-discovery-using-beacons
-
Genetic Legacy of Punan Hunter-Gatherer Groups in Indonesian Borneo
Study
EGAS00001004471
-
RNA sequencing from patient-derived intestinal organoids
Dataset
EGAD50000000492
-
dbGaP Collection: Open Translational Science in Schizophrenia (OPTICS)
Study
phs000887
-
Interpreting molecular role of DNA variants associated with Crohn's Disease through integrative analysis of open chromatin, epigenome and transcriptome data in diverse and relevant tissues and cells
Study
phs001418
-
Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)
Study
phs000391
-
Broccoli Sprouts Extracts Trial (BEST-COPD-BioLINCC)
Study
phs004022
-
DAC for "Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis"
Dac
EGAC50000000076
-
Compilation of Aggregate Genomic Data for General Research Use
Study
phs000501
-
Next-generation sequencing raw data from metastatic prostate cancer biopsies - observational study Vall d'Hebron Institute of Oncology (Ethics committee code PR-AG-5248)
Dac
EGAC50000000448
-
IHEC DEEP Release August 2016
Study
EGAS00001001937
-
A Genome-Wide Association Study of Peripheral Arterial Disease
Study
phs000203
-
Providing safe access to sensitive human data across borders: Federated EGA becomes a reality
Blog
safe-access-to-sensitive-human-data-federated-ega
-
Germline Whole-Exome Sequencing of Lung Cancer in EAGLE
Study
phs002496
-
NHLBI TOPMed: Genetics of Cardiometabolic Health in the Amish
Study
phs000956
-
Genome-wide expression profiles to compare array-based, RNAseq and NanoString technologies in patients with resected pancreatic ductal carcinoma.
Study
EGAS00001002501
-
The Oral Microbiome and Head and Neck Cancer
Study
phs004018
-
A unidirectional histone code in bidirectional promoters across cell types
Study
EGAS00001001656
-
EGAD00000000092
Dataset
EGAD00000000092
-
EGAD00000000093
Dataset
EGAD00000000093
-
Poland WES - The Genomic Map of Poland in Open Access
Dataset
EGAD50000000130
-
EGAD00000000084
Dataset
EGAD00000000084
-
EGAD00000000085
Dataset
EGAD00000000085
-
Human four week embryo head as reference for generating an enhancer compendium for neuronal and neural crest development using neural tube organoids.
Study
EGAS50000001031
-
HELIUS cohort gut microbiome batch2
Dataset
EGAD00001009732
-
HELIUS cohort gut microbiome
Dataset
EGAD00001004106
-
503 genotypes from Inner Asia used in 'Close inbreeding and low genetic diversity in Inner Asian human populations despite geographical exogamy' publication
Study
EGAS00001002951
-
Inherited Genetic Variation and Predisposition to Testicular Germ Cell Tumor: UPenn Local TGCT Study
Study
phs001307
-
Skin Adenocarcinoma Genome Sequencing
Dataset
EGAD00001001100
-
EGAD00010000750
Dataset
EGAD00010000750
-
EGAD00010000752
Dataset
EGAD00010000752
-
Pharmacogenomic landscape of patient-derived cells informs precision oncology therapy
Study
EGAS00001002515
-
Association studies using the Metabochip array - Samples analysed by the WTCCC (1958 British Birth Cohort (58BC), Hypertension cohort (HT), Type 2 Diabetes Cohort (T2D) and Coronary Artery Disease (CAD) cohort)
Study
EGAS00000000115
-
The Genomic Map of Poland in Open Access
Study
EGAS50000000096
-
Genetic Discovery and Application in a Clinical Setting: Continuing a Partnership (eMERGE Phase II)
Study
phs000948